My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 611

    1.

    The role of individual susceptibility in cancer burden related to environmental exposure.

    Bartsch H, Hietanen E.

    Environ Health Perspect. 1996 May;104 Suppl 3:569-77. Review.PMID: 8781385 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.

    Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM.

    Int J Hyg Environ Health. 2003 Jun;206(3):149-71. Review.PMID: 12872524 [PubMed - indexed for MEDLINE]Related articles

    3.

    Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.

    Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG.

    J Natl Cancer Inst. 1995 Jun 21;87(12):902-7. Erratum in: J Natl Cancer Inst 1996 Nov 6;88(21):1595. PMID: 7666479 [PubMed - indexed for MEDLINE]Related articles

    4.

    Molecular epidemiology in cancer research.

    Collins AR.

    Mol Aspects Med. 1998 Dec;19(6):359-432. Review.PMID: 10385877 [PubMed - indexed for MEDLINE]Related articles

    5.

    Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.

    Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K.

    Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):3-28. Review.PMID: 10667460 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Environmental and chemical carcinogenesis.

    Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

    Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.PMID: 15489140 [PubMed - indexed for MEDLINE]Related articles

    7.

    Genetic polymorphisms and lung cancer susceptibility: a review.

    Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM.

    Lung Cancer. 2002 Sep;37(3):241-56. Review.PMID: 12234692 [PubMed - indexed for MEDLINE]Related articles

    8.

    Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.

    Autrup H.

    Mutat Res. 2000 Jan 3;464(1):65-76. Review.PMID: 10633178 [PubMed - indexed for MEDLINE]Related articles

    9.

    Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.

    Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, Singletary ES, Hassan MM, Li D.

    Carcinogenesis. 2002 Feb;23(2):301-6.PMID: 11872636 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Interaction between dose and susceptibility to environmental cancer: a short review.

    Hietanen E, Husgafvel-Pursiainen K, Vainio H.

    Environ Health Perspect. 1997 Jun;105 Suppl 4:749-54. Review.PMID: 9255556 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.

    Ko Y, Abel J, Harth V, Bröde P, Antony C, Donat S, Fischer HP, Ortiz-Pallardo ME, Thier R, Sachinidis A, Vetter H, Bolt HM, Herberhold C, Brüning T.

    Cancer Res. 2001 Jun 1;61(11):4398-404.PMID: 11389067 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.

    Bartsch H, Rojas M, Nair U, Nair J, Alexandrov K.

    Cancer Detect Prev. 1999;23(6):445-53.PMID: 10571654 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cancer and phase II drug-metabolizing enzymes.

    Sheweita SA, Tilmisany AK.

    Curr Drug Metab. 2003 Feb;4(1):45-58. Review.PMID: 12570745 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.

    Badawi AF, Stern SJ, Lang NP, Kadlubar FF.

    Prog Clin Biol Res. 1996;395:109-40. Review.PMID: 8895986 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.

    Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.

    Carcinogenesis. 2003 Oct;24(10):1671-6. Epub 2003 Jul 4.PMID: 12844488 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer.

    Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M.

    Cancer Res. 1996 Jan 1;56(1):72-6.PMID: 8548778 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.

    Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J.

    Cancer Detect Prev. 2003;27(2):139-46.PMID: 12670526 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.

    Suzuki S, Muroishi Y, Nakanishi I, Oda Y.

    J Gastroenterol. 2004;39(3):220-30.PMID: 15064998 [PubMed - indexed for MEDLINE]Related articles

    19.

    Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose.

    Kawajiri K, Nakachi K, Imai K, Hayashi S, Watanabe J.

    Princess Takamatsu Symp. 1990;21:55-61.PMID: 2134690 [PubMed - indexed for MEDLINE]Related articles

    20.

    Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.

    Kiyohara C.

    J Epidemiol. 2000 Sep;10(5):349-60. Review.PMID: 11059519 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity